B&B News

Susan “Nicki” Hastings, MD, MHS, was named chief for the Division of General Internal Medicine, effective December 16, 2024. Dr. Hasting’s clinical and academic interests in health science research build on the legacy of former division chiefs, Dr. Eugene Oddone and Dr. Ebony Boulware.

Does Ed Hammond, PhD, process oxygen twice as fast as the average man? It’s as good as any other explanation for how the esteemed biomedical informatician climbed Mt.

It took until he was 20 years old before Samuel Ndukwe first saw a physician who looked like him. Recognizing that representation matters, the second-year Duke medical student is now doing all he can to make sure young Black men see themselves represented in the medical field much earlier than he did.

Biostatistics PhD student, Peijin Wang, has received one of the Student Paper Travel Awards from the International Conference on Health Policy Statistics (ICHPS). The award recognizes her paper titled “Integrating Randomized Controlled Trial and External Control Data Using Balancing Weights: A Comparison of Estimands and Estimators.”

Nicoleta J. Economou-Zavlanos, PhD, has been named director of the newly established Duke Health AI Evaluation & Governance Program. She will be charged with driving the trustworthy, responsible, and equitable integration of AI in health care.

The Web of Science ranking of the world’s most highly-cited scientists was released recently. These are the authors of influential papers that other scientists point to when making their arguments.

Human genetics research is highly collaborative, relying on scientists with diverse expertise and experience from around the country working together to understand how the human genome works.

David Carlson, PhD, has assumed the role of director of graduate studies for the PhD Program in Computational Biology and Bioinformatics.

Baoshan Zhang, Biostatistics PhD student, has been selected for the FDA-OCE-ASA Oncology Education Fellowship.

A large-scale clinical trial led by Duke School of Medicine and Vanderbilt showed the asthma medication montelukast fails to cut COVID-19 recovery time. While several antiviral drugs have shown promise, there is still a need for more options, especially for people with mild to moderate cases.